Matthew Rotenberg
Directeur/Membre du Conseil chez Biosimilars Canada
Profil
Matthew Rotenberg is currently a Director at Biosimilars Canada.
Prior to this, he was the Chief Executive Officer at Fresenius Kabi Canada Ltd.
from 2000 to 2023.
Postes actifs de Matthew Rotenberg
| Sociétés | Poste | Début |
|---|---|---|
Biosimilars Canada
 Biosimilars Canada Miscellaneous Commercial ServicesCommercial Services Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association that provides leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines. Biosimilars Canada is based in Toronto, Canada. The member companies of Biosimilars Canada are involved in the development and marketing of biosimilar medicines. The organization advocates for policies that support the timely approval, reimbursement, market acceptance, and expanded use of biosimilar medicines. Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them. | Directeur/Membre du Conseil | - |
Anciens postes connus de Matthew Rotenberg
| Sociétés | Poste | Fin |
|---|---|---|
Fresenius Kabi Canada Ltd.
 Fresenius Kabi Canada Ltd. Pharmaceuticals: MajorHealth Technology Fresenius Kabi Canada Ltd. health care services. The firm offers intravenous specialty and generic medicines, transfusion technologies, infusion therapies, parental nutrition, and medical devices. The company was founded in 1999 and is headquartered in Toronto, Canada. | Directeur Général | 01/07/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Fresenius Kabi Canada Ltd.
Fresenius Kabi Canada Ltd. Pharmaceuticals: MajorHealth Technology Fresenius Kabi Canada Ltd. health care services. The firm offers intravenous specialty and generic medicines, transfusion technologies, infusion therapies, parental nutrition, and medical devices. The company was founded in 1999 and is headquartered in Toronto, Canada. | Health Technology |
Biosimilars Canada
Biosimilars Canada Miscellaneous Commercial ServicesCommercial Services Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association that provides leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines. Biosimilars Canada is based in Toronto, Canada. The member companies of Biosimilars Canada are involved in the development and marketing of biosimilar medicines. The organization advocates for policies that support the timely approval, reimbursement, market acceptance, and expanded use of biosimilar medicines. Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them. | Commercial Services |
